SEC Form 4 · accession 0001144204-15-071543
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert G L Shorr
Director
Period of report
Dec 16, 2015
Accepted (ET)
Dec 17, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137883
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 16, 2015 | S | 10,800 | $2.71 | D | 28,399 | D |
Table II — derivative securities
No Table II lines on this filing.